Society Of Urologic Oncology Clinical Trials Consortium
- Assets
- $1.0m
- Revenue
- $626.6k
- Investments
- $0.0
- Employees
- 0
- Location
- Schaumburg, IL
- Founding
- 03/2010
- Data as of
- 04/2022
- EIN
- 26-2943602
Organization Overview
Society Of Urologic Oncology Clinical Trials Consortium is located in Schaumburg, IL. The organization was established in 2010. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Society Of Urologic Oncology Clinical Trials Consortium is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 04/2022, Society Of Urologic Oncology Clinical Trials Consortium generated $626.6k in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 26.1% each year . All expenses for the organization totaled $183.6k during the year ending 04/2022. While expenses have increased by 3.1% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE SOCIETY IS A NATIONAL ALLIANCE OF LEADING ACADEMIC AND COMMUNITY BASED URO-ONCOLOGISTS COMMITTED TO THE FOLLOWING - TO FURTHER UROLOGY RESEARCH AND PHARMACEUTICAL TRIALS, - TO OFFER & PROVIDE FOR THE BEST POSSIBLE APPROACH TO DISEASE EDUCATION AND MANAGEMENT PROVIDING FOR BETTER PATIENT OUTCOMES, - TO PROVIDE EDUCATION FOR THE PROFESSION TO FURTHER THE LEARNINGS CONDUCTED THROUGH THE PROFESSION, - AND TO ALLOW CLINICIANS TO BE AWARE OF EXISTING RESEARCH, WHICH ADVANCES FURTHER CLINICAL EDUCATION AND HYPOTHESES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE CONSORTIUM ASSISTS DOCTORS AND HOSPITALS CONDUCTING CLINICAL TRIALS WITH EXPEDITED CONCEPT AND PROTOCOL REVIEW, STANDARDIZED PROTOCOL AND CONTRACT LANGUAGE, AND CENTRALIZED DATA MANAGEMENT TO HELP TEST NEEDED THERAPIES MORE RAPIDLY THE SUO-CTC DIRECTS REVENUES GENERATED FROM SPONSOR AGREEMENTS TO FUND THE COLLECTIVE ACADEMIC, RESEARCH, CORPORATE AND ADMINISTRATIVE OBJECTIVES OF THE CONSORTIUM IN RETURN THE SUO-CTC OFFERS A VARIETY OF VALUE-ADDED SERVICES WHICH ARE OF SHARED BENEFIT TO THE URO-ONCOLOGY COMMUNITY, PHARMACEUTICAL INDUSTRY BOTH LOCALLY AND ABROAD.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Robert Guy Uzzo MD MBA Facs Past President | OfficerTrustee | 1 | $0 |
Gennady Bratslavsky MD President | OfficerTrustee | 1 | $0 |
Michael Edward Woods MD Facs Treasurer | OfficerTrustee | 1 | $0 |
Ms Pam Murphy Executive Dir. | Officer | 1 | $0 |
Adam Stuart Kibel MD Director | Trustee | 1 | $0 |
Kelly L Stratton MD Fac Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $626,645 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $626,645 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $168,244 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $4,000 |
| Advertising and promotion | $0 |
| Office expenses | $135 |
| Information technology | $456 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $980 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $1,212 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $8,564 |
| All other expenses | $0 |
| Total functional expenses | $183,608 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $905,441 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $114,100 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $1,019,541 |
| Accounts payable and accrued expenses | $21,320 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $19,648 |
| Total liabilities | $40,968 |
| Net assets without donor restrictions | $978,573 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,019,541 |
Grants Recieved
Over the last fiscal year, we have identified 1 grants that Society Of Urologic Oncology Clinical Trials Consortium has recieved totaling $5.
| Awarding Organization | Amount |
|---|---|
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $5 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Ulta Beauty Charitable Foundation Bolingbrook, IL | $10,193,540 | $17,881,824 |
University Of Kentucky Markey Cancer Foundation Inc Lexington, KY | $19,134,513 | $1,289,166 |
University Of Chicago Cancer Research Foundation Chicago, IL | $9,937,002 | $3,131,456 |
Bear Necessities Pediatric Cancer Foundation Chicago, IL | $2,315,118 | $1,700,490 |
Iowa Oncology Research Association Des Moines, IA | $652,663 | $1,300,527 |
Equal Hope Chicago, IL | $2,250,757 | $1,797,220 |
Cancer Research Foundation Chicago, IL | $11,396,644 | $1,076,545 |
Proton Collaborative Group Inc Warrenville, IL | $1,110,674 | $1,189,051 |
A Just Harvest Chicago, IL | $531,907 | $887,629 |
Hippocratic Cancer Research Foundation Inc Wheeling, IL | $548,559 | $543,863 |
Wood Hudson Cancer Research Laboratory Inc Newport, KY | $54,376,827 | $1,503,910 |
Jeffrey Pride Foundation Inc Barrington, IL | $90,138 | $492,555 |